Irene Beecham-Debiram

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Patient experiences of Cytosponge: a qualitative study.

Patient experiences of Cytosponge: a qualitative study.

Journal: Frontline gastroenterology

Published: June 05, 2023

Measuring patient experience of Cytosponge using the Newcastle ENDOPREM.

Measuring patient experience of Cytosponge using the Newcastle ENDOPREM.

Journal: Frontline gastroenterology

Published: August 09, 2022

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial.

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial.

Journal: BMC gastroenterology

Published: July 14, 2022

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study.

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study.

Journal: EClinicalMedicine

Published: July 04, 2022

Breath Biopsy® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection.

Breath Biopsy® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection.

Journal: Journal of clinical and translational hepatology

Published: June 30, 2022

Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial.

Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial.

Journal: BMJ open

Published: April 08, 2022

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot.

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot.

Journal: The Lancet. Oncology

Published: October 05, 2021

Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment.

Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment.

Journal: Clinical and translational gastroenterology

Published: October 23, 2020

Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting.

Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting.

Journal: International journal of cancer

Published: August 24, 2020

Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic.

Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic.

Journal: The lancet. Gastroenterology & hepatology

Published: July 19, 2020

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.

Journal: Lancet (London, England)

Published: March 26, 2020

Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma.

Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma.

Journal: Nature genetics

Published: October 21, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026